KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

Investment firm KKR (NYSE:KKR) announced on Wednesday the acquisition of a majority stake in biopharma royalty acquisition company, HealthCare Royalty Partners. The acquisition marks KKR's expansion ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

British healthcare real estate investor Assura said on Friday that it maintains its support for a takeover bid by Primary ...

The Company's management team, led by CEO Joseph Davi, will continue to lead Med-Metrix and remain significant owners of the business. Med-Metrix's prior owner, A&M Capital ("AMC"), will retain a ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.